Corporate manslaughter scrutiny is intensifying across the NHS

For decades, serious patient safety failures within the NHS have largely been addressed through regulation, public inquiries, disciplinary action and improvement programmes. These mechanisms remain central to healthcare oversight, but there has been a significant shift in how law enforcers and policymakers view systemic failures.

Recent developments, including Amos’s report on the Independent National Maternity and Neonatal Investigation, the Ockenden Review into maternity services at Nottingham University Hospitals NHS Trust, Thirlwall Inquiry and the Lampard Inquiry, point to increasing scrutiny of organisational culture, leadership decisions and patient safety governance across the NHS. The focus is shifting from isolated clinical incidents to the systems, behaviours and decision-making structures that sit behind them.

For NHS trusts, the greatest risk is being unable to demonstrate that concerns were escalated, evidence was preserved, risks were addressed and appropriate challenge was applied when serious patient safety issues emerged.

Why corporate manslaughter matters to NHS boards

The NHS and healthcare providers operate in one of the most heavily regulated sectors in the UK. While prosecutions for corporate manslaughter are relatively uncommon, recent legislative reforms have significantly expanded corporate criminal liability. The Crime and Policing Act 2026 broadens the circumstances in which criminal wrongdoing by senior managers may be attributed to an organisation, increasing the importance of effective governance, oversight and accountability across the NHS and healthcare providers. In addition, recent high-profile inquiries and reviews show an increasing focus on the role of leadership, governance and organisational culture in serious incidents. While the offence of corporate manslaughter has not changed, healthcare providers should assume that governance arrangements, escalation decisions, documentation and oversight processes may receive closer scrutiny following serious incidents.

This means investigators of NHS trusts and healthcare providers may look more closely at:

• Board oversight and decision-making
• Escalation of patient safety concerns
• Organisational culture
• Record-keeping and evidence preservation
• Speaking-up arrangements
• The actions of senior leaders when significant risks are identified.

Five board-level governance lessons from recent NHS inquiries

1. Early escalation triggers must be applied

Operation Duet is examining how organisations and individual leaders respond when there is an increase in fatalities. It says boards should put escalation triggers in place to respond to unusual harm patterns (such as spikes in mortality or patient deterioration). These triggers should automatically prompt executive oversight and independent challenge.

This observation does not draw conclusions about events at the Countess of Chester Hospital but does reflect the governance implications arising from the investigation.

2. Maintaining the integrity of evidence is a patient safety control

An arrest on suspicion of perverting the course of justice highlights the importance of maintaining strong controls over record-keeping, audit trails and the preservation of relevant materials when serious safety concerns arise. Boards should treat information governance during such incidents as part of the patient safety system, rather than solely a legal or communications issue.

3. Internal review is not a substitute for independent challenge

Where allegations may show that the responses of leaders were criminally negligent, boards should make sure that independent, external bodies challenge leaders’ decision-making processes. This may include independent clinical review, external oversight and liaison with regulators or the police where appropriate.

4. A speaking-up culture must function as an assurance mechanism

Independent organisational research shows that staff sometimes raise concerns late, or feel that their concerns are not acted upon, which can undermine confidence in governance. NHS Trusts and healthcare providers must therefore recognise that the freedom to speak up is not only a cultural aspiration but a control that must be reinforced and supported at board level.

5. Clarity of accountability across corporate and individual risk

Public reporting highlights the distinction between corporate manslaughter (organisational failings) and gross negligence manslaughter (individual actions or inactions). Boards should make sure that governance frameworks clearly define decision rights, escalation responsibilities and documentation requirements for high-risk situations, particularly across clinical, operational and executive interfaces.

Practical actions for NHS boards - audit and risk committees

Review escalation arrangements

Confirm that board-approved escalation triggers exist for unusual harm patterns, repeated incidents and serious patient safety concerns.

Test evidence preservation processes

Assess whether the organisation can demonstrate strong controls over records, audit trails and information governance.

Measure speaking-up effectiveness

Review both quantitative and qualitative information relating to speaking-up concerns and organisational learning.

Define independent challenge triggers

Establish clear criteria for commissioning external clinical reviews or governance reviews.

Assess board assurance reporting

Make sure board papers provide enough evidence of challenge, action tracking and accountability.

Questions healthcare boards should ask now

Escalation and governance

• What are our triggers for executive escalation?
• How do we demonstrate that escalation procedures have been followed?
• Are governance responsibilities clearly defined?

Patient safety and evidence

• How do we preserve records during serious incidents?
• How are retrospective amendments controlled and monitored?
• Can we give evidence of our decision-making processes?

Culture and accountability

• Do staff feel confident raising concerns?
• How quickly are concerns investigated?
• How do we make sure lessons are learned and embedded?

What this means for NHS and healthcare leaders

Corporate manslaughter remains a high-threshold offence. However, recent inquiries, reviews and legislative developments have reinforced a broader governance lesson: healthcare organisations must be able to demonstrate effective leadership, robust governance and a culture that supports transparency and learning.

Boards that can evidence strong escalation processes, independent challenge, effective speaking-up arrangements and clear accountability frameworks will be better placed to protect patients, support staff and withstand increasing scrutiny.

If you'd like to discuss how recent legal developments and healthcare inquiries could impact your organisation, please get in touch with Clive Makombera or your usual RSM contact.

Latest related insights